Focused on Every Breath
Diagnose Asthma with Confidence
Methapharm Respiratory’s ambition is to ensure people with asthma symptoms have the right diagnosis.
Methapharm Respiratory is part of Methapharm Specialty Pharmaceuticals.
Asthma is one of the most prevalent chronic respiratory conditions globally. Ensuring that patients have the right diagnosis is the first step in improving the lives of millions of people who struggle with the disease. We provide clinicians with the diagnostic tools to accurately assess people experiencing symptoms like cough, wheeze and shortness of breath. Our globally trusted diagnostic products are recommended in the ERS/ATS guidelines as well as other international practice guidelines.
Bronchial challenge tests with Provocholine (methacholine) and Aridol (mannitol), along with measuring the level of fractional exhaled nitric oxide (FeNO) in human breath using Vivatmo pro, are objective and evidence-based measures of airway hyperresponsiveness and inflammation. Both are key features of asthma. The right diagnosis is key.
As a committed partner, we also offer training and education (CRCE) at no cost to support clinicians as they help patients along their diagnostic journey.
NOW AVAILABLE!
NOW AVAILABLE!
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Consider the consequences of an incorrect diagnosis of asthma:
Ineffective treatments
Inappropriate medications
Poor quality of life
Impact on work and school performance
Blog
Asthma Peak Week
Summer is rapidly coming to a close. Children, and parents, are preparing to return to school. There is the excitement of shoe shopping, buying supplies, learning who their teacher will be, getting their class schedule and new books. As school resumes and the...
Fractional Exhaled Nitric Oxide (FeNO) in Clinical Practice
Fractional Exhaled Nitric Oxide (FeNO) testing has emerged as a valuable tool in both the diagnosis and management of asthma. It is a non-invasive, quick, and easy test that measures the concentration of nitric oxide in exhaled breath. This helps provide insights...
Test Before Diagnosing
262 million people world-wide have asthma. Twenty-five million Americans have asthma. Ten people die each day in the United States from an asthma exacerbation. It is a heterogenous disease that can be difficult to diagnose and manage. There are objective tests...